Register for our free email digests:
Piramal Enterprises Limited
http://www.piramal.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Piramal Enterprises Limited
Asia Deal Watch: Promethera Calls On Hao Tian For Asian JV To Advance Its Liver Candidates
Plus recent deals involving BeiGene, Assembly Biosciences, Piramal, Medivant, Revitope, Junshi, JW Therapeutics, Eureka, Acepodia, Chiesi, Bayer, NewG Lab, AnHeart
KKR Deal Bolsters JB Chemicals’ Expansion Efforts
US private equity firm KKR is to acquire a majority stake in JB Chemicals, accelerating the Indian group's growth plans in branded formulations. Post a 54% stake acquisition for $414m via part-purchase from the founders and an open offer at INR745 per share, KKR's final stake could rise to 64.9% if founders offer more shares.
KKR Deal To Bolster JB Chemicals’ Expansion Efforts
US private equity firm KKR to acquire a majority stake in JB Chemicals, accelerating the Indian group's growth plans in branded formulations. Post a 54% stake acquisition for $414m via part-purchase from the founders and an open offer at INR745/share, KKR's final stake could rise to 64.9% if founders offer more shares.
Carlyle Pays Almost $500m For A Fifth Of Piramal Pharma
Private equity group Carlyle has acquired 20% of Piramal's pharma business for close to $500m, with the Indian group expected to use the capital raise to bolster organic and inorganic growth and deleverage the balance sheet.
Company Information
- Industry
-
Pharmaceuticals
- Generic Drugs
-
Biotechnology
- Drug Discovery Tools
- Other Names / Subsidiaries
-
- Ash Stevens Inc.
- Life Molecular Imaging
- Piramal Critical Care
- Piramal Enterprises Ltd.
- Piramal Healthcare, Ltd.
- Piramal Imaging SA
- Piramal Life Sciences, Ltd.
- Piramal Pharma Solutions